Document is current

Any future updates will be listed below

Correction: The impact of tocilizumab treatment on the severity of inflammation and survival rates in sepsis is significantly influence by the timing of administration

Crossref DOI link: https://doi.org/10.1007/s10787-025-01748-4

Published Online: 2025-04-26

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark